Who has invested in OTR Therapeutics?

True Light Capital, LAV, Pfizer Ventures, Sirona Capital are named among the investors backing OTR Therapeutics.

OTR Therapeutics Funding: $100M Raised, Series A (2025)

OTR Therapeutics funding overview

OTR Therapeutics is based in Shanghai, China. OTR Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2025. The round record for OTR Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include True Light Capital, LAV, Pfizer Ventures, Sirona Capital. 4 distinct backers are named across the disclosed rounds.

OTR Therapeutics at a glance

Total raised: $100M
Latest round: Series A
Latest round date: June 2025
Headquarters: Shanghai, China
Notable investors: True Light Capital, LAV, Pfizer Ventures, Sirona Capital

Frequently asked about OTR Therapeutics funding

How much has OTR Therapeutics raised?: OTR Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in OTR Therapeutics?: True Light Capital, LAV, Pfizer Ventures, Sirona Capital are named among the investors backing OTR Therapeutics.
What was the latest OTR Therapeutics funding round?: The most recent disclosed round is a Series A, announced in June 2025.
Where is OTR Therapeutics based?: OTR Therapeutics is based in Shanghai, China.
When did OTR Therapeutics last raise?: The last disclosed OTR Therapeutics round closed in June 2025 at Series A.

Round data for OTR Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.

OTR Therapeutics Funding: $100M Raised, Series A (2025)

OTR Therapeutics funding overview

OTR Therapeutics at a glance

Frequently asked about OTR Therapeutics funding

Companies related to OTR Therapeutics (19)

Browse related funding lists (6)